WTF?Like you stated? You stated that Biden lowered drug prices? Now to support that you google search and present us with the fact that Biden did not lower drug prices but a bill, not of Biden's design, allows medicare to negotiate drug prices for people on Medicare?
Medicare is not available to everyone, allowing negotiations does not mean that drug prices will be lower, in fact, it has already resulted in the cost of 500 drugs to go up!
They ALWAYS go up.
How do prescription drug costs in the United States ...
Peterson-KFF Health System Tracker
https://www.healthsystemtracker.org › chart-collection
Feb 8, 2022 — In 2019, the U.S. spent more than $1,000 per person on prescribed medicines, an amount higher than any peer nation. This chart collection ...
In 2019 (the latest year with internationally comparable data from the OECD), the U.S. spent $1,126 per capita on prescribed medicines, while comparable countries spent $552 on average. This includes spending from insurers and out-of-pocket costs from patients for prescription drugs filled at the pharmacy.
Per capita prescribed medicine spending in the U.S. grew by 69% from 2004 to 2019, compared to 41% in comparable countries, on average. During this period growth rates fluctuated, with modest growth in U.S. from 2006 to 2013, and sharp increases in growth in 2014 and 2015 which were largely driven by the introduction of new, highly priced treatments.
Well, NO SHIT.What else does your link state?
Oh, I see, it is expanding subsidies and you call that a decrease in the cost of drugs for everyone
SmokinOP, you are full of shit and when challenged, your narrative completely changed to people who are on Medicare and you have shown that the prices have not lowered, and that they are now being subsidized to artificially make it appear the prices are lower.
Lowering taxes for billionaires are being subsidized by everyone else.
Sure they will.They will negotiate higher prices than subsidize the cost. Sounds like a win win, for everyone but the taxpayer.
Just like this.
Pharma's $50 billion tax windfall for investors
Axios
https://www.axios.com › Economy
Feb 22, 2018 — Nine drug companies are spending a combined $50 billion on new share buyback ...
The pharmaceutical industry is using a large portion of its windfall from Republicans' corporate tax cuts to boost its stock prices. Nine drug companies are spending a combined $50 billion on new share buyback programs, a sum that towers over investments in employees or drug research and development.
The bottom line: All of those buybacks were announced during or after the passage of the Republican tax bill. That money is enriching hedge funds, other Wall Street investors and top drug company executives, but it isn't necessarily helping patients.